- Home
- Products
- Customized FluoroAb™
- LYPD3
- Anti-LYPD3 MAb (Clone 3)-iFluor® 405 Succinimidyl Ester
Anti-LYPD3 MAb (Clone 3)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2066)
This product is comprised of an Anti-LYPD3 Antibody (Clone 3) labeled with iFluor® 405 Succinimidyl Ester. iFluor® 405 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- LYPD3
- Overview
- Anti-LYPD3 Antibody (Clone 3)
- Species Reactivity
- Human
- Name
- iFluor® 405 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 403/427
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TNFRSF17 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6454)
- Sibrotuzumab-OGreen (CAT#: ADC-FL-1439)
- Anti-TNFRSF9 MAb (Clone 4)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1524)
- Anti-CD4 MAb (Clone 37)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1170)
- Anti-IL5RA MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11402)
- Anti-MSLN MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14291)
- Itolizumab-iFluor 647 (CAT#: ADC-FL-873)
- Anti-EDA MAb (Clone 3)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11752)
- Ticilimumab-iFluor 488 (CAT#: ADC-FL-1047)
- Anti-MS4A1 MAb (Clone 5)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5018)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS2066. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-111 | Anti-LYPD3-lysine-toxophore ADC-2 | lysine | toxophore loading |
| ADC-W-561 | Anti-LYPD3-auristatin ADC | Auristatin | |
| ADC-W-110 | Anti-LYPD3-lysine-toxophore ADC-1 | lysine | toxophore loading |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.